CHAMPIONS ONCOLOGY, INC. Debt Conversion, Converted Instrument, Rate
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Debt Conversion, Converted Instrument, Rate of 5.00% for the 0-month period ending 2014-12-01, per its 10-Q filed 2015-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentRate · last filed 2015-03-17
- 2014-12-01: Debt Conversion, Converted Instrument, Rate 0 month 5.00%.
| Period end | Debt Conversion, Converted Instrument, Rate 0 month |
|---|---|
| 2014-12-01 | 5.00% 10-Q · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |